GlassScriptPhysician profile
Robert Scott Bradley
NPI 1194740266
$11,161.04
in general payments reported to CMS, 2019-2025
40 companies · $1,416 in 2025
The $1,416 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,543 · 2020: $541 · 2021: $2,080 · 2022: $1,752 · 2023: $1,200 · 2024: $2,628 · 2025: $1,416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,194 · Travel and Lodging: $1,050.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,194.01 |
| Travel and Lodging | $1,050.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $1,652.36 | 2021 | |
| Medtronic, INC. | $1,521.57 | 2021-2025 | Micra, Linq II, Plasmablade(Tm) |
| Abbott Laboratories | $1,362.19 | 2019-2025 | Xience Skypoint, Freestyle Libre 3, Assurity |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $953.88 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $863.52 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $646.40 | 2019-2024 | Xarelto |
| Amgen INC. | $630.15 | 2019-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $605.51 | 2019-2025 | Jardiance |
| Pfizer INC. | $472.22 | 2019-2025 | |
| Boston Scientific Corporation | $323.33 | 2019-2024 | Wolverine Coronary Cutting Balloon, Watchman Access System, Guidezilla |
| E.R. Squibb & Sons, L.L.C. | $287.91 | 2019-2025 | Camzyos, Eliquis |
| Kestra Medical Technology Services, INC. | $276.07 | 2024-2025 | Assure Wcd |
| Novo Nordisk INC | $224.17 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $190.24 | 2019-2023 | Andexxa, Farxiga |
| Regeneron Healthcare Solutions, INC. | $116.96 | 2019-2025 | Dupixent |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $110.68 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Biotronik INC. | $104.47 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $102.49 | 2023-2025 | Verquvo, Capvaxive |
| Cardiovascular Systems INC. | $70.16 | 2019 | |
| Philips North America LLC | $60.21 | 2022-2025 | (9278) Bridge, Ambulatory Monitoring & Diagnostics Undivided |
| Acist Medical Systems, INC. | $56.28 | 2025 | |
| Verona Pharma, INC. | $53.73 | 2025 | Ohtuvayre |
| Baxter Healthcare | $52.42 | 2024-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Cardiac Ambulatory Monitor |
| Medtronic Vascular, INC. | $48.89 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $46.89 | 2022-2024 | |
| Kiniksa Pharmaceuticals, LTD. | $40.52 | 2022-2023 | Arcalyst |
| Glaxosmithkline, LLC. | $40.12 | 2019-2021 | |
| Lexicon Pharmaceuticals, INC. | $37.24 | 2023-2024 | Inpefa |
| Stryker Corporation | $32.43 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Terumo Medical Corporation | $27.33 | 2019-2021 | |
| Abiomed | $20.57 | 2025 | |
| Lundbeck LLC | $18.45 | 2019 | |
| Ekos Corporation | $18.29 | 2019 | |
| Jazz Pharmaceuticals INC. | $15.38 | 2020 | |
| Viatris Specialty LLC | $14.87 | 2025 | Yupelri |
| Amarin Pharma, INC. | $14.29 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.25 | 2020 | |
| Teleflex LLC | $13.15 | 2022 | |
| Sanofi-Aventis U.S. LLC | $11.50 | 2019 | |
| Circassia INC. | $10.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Bradley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.